IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients


The contribution of inflammation to neurodegenerative diseases is increasingly recognized, but the role of inflammation in sporadic amyotrophic lateral sclerosis (sALS) is not well understood and no animal model is available. We used enzyme-linked immunosorbent assays (ELISAs) to measure the cytokine interleukin-17A (IL-17A) in the serum of ALS patients (n… (More)
DOI: 10.1186/1742-2094-7-76


11 Figures and Tables